Published on FiercePharma (http://www.fiercepharma.com)

FDA cancels meeting on new Cymbalta use

By tracy
Created Jan 6 2010 - 10:47am

The FDA has canceled a meeting to review Eli Lilly's antidepressant Cymbalta for a new use against chronic pain, sending the company's stock downward. Report [1]

Source URL: http://www.fiercepharma.com/story/fda-cancels-meeting-new-cymbalta-use/2010-01-06

Links:
[1] http://www.indystar.com/article/20100105/BUSINESS/1050376/1003/BUSINESS/FDA-cancels-Lilly-meeting-share-price-falls